Tassan J P, Schultz S J, Bartek J, Nigg E A
Swiss Institute for Experimental Cancer Research (ISREC), Epalinges.
J Cell Biol. 1994 Oct;127(2):467-78. doi: 10.1083/jcb.127.2.467.
The activity of cyclin-dependent kinases (cdks) depends on the phosphorylation of a residue corresponding to threonine 161 in human p34cdc2. One enzyme responsible for phosphorylating this critical residue has recently been purified from Xenopus and starfish. It was termed CAK (for cdk-activating kinase), and it was shown to contain p40MO15 as its catalytic subunit. In view of the cardinal role of cdks in cell cycle control, it is important to learn if and how CAK activity is regulated during the somatic cell cycle. Here, we report a molecular characterization of a human p40MO15 homologue and its associated CAK activity. We have cloned and sequenced a cDNA coding for human p40MO15, and raised specific polyclonal and monoclonal antibodies against the corresponding protein expressed in Escherichia coli. These tools were then used to demonstrate that p40MO15 protein expression and CAK activity are constant throughout the somatic cell cycle. Gel filtration suggests that active CAK is a multiprotein complex, and immunoprecipitation experiments identify two polypeptides of 34 and 32 kD as likely complex partners of p40MO15. The association of the three proteins is near stoichiometric and invariant throughout the cell cycle. Immunocytochemistry and biochemical enucleation experiments both demonstrate that p40MO15 is nuclear at all stages of the cell cycle (except for mitosis, when the protein redistributes throughout the cell), although the p34cdc2/cyclin B complex, one of the major purported substrates of CAK, occurs in the cytoplasm until shortly before mitosis. The absence of obvious changes in CAK activity in exponentially growing cells constitutes a surprise. It suggests that the phosphorylation state of threonine 161 in p34cdc2 (and the corresponding residue in other cdks) may be regulated primarily by the availability of the cdk/cyclin substrates, and by phosphatase(s).
细胞周期蛋白依赖性激酶(cdks)的活性取决于与人类p34cdc2中苏氨酸161相对应的一个残基的磷酸化。最近,一种负责磷酸化这个关键残基的酶已从非洲爪蟾和海星中纯化出来。它被称为CAK(cdk激活激酶),并且已证明其催化亚基为p40MO15。鉴于cdks在细胞周期调控中的关键作用,了解CAK活性在体细胞周期中是否以及如何受到调节非常重要。在此,我们报告了人类p40MO15同源物及其相关CAK活性的分子特征。我们克隆并测序了编码人类p40MO15的cDNA,并制备了针对在大肠杆菌中表达的相应蛋白质的特异性多克隆和单克隆抗体。然后利用这些工具证明p40MO15蛋白表达和CAK活性在整个体细胞周期中是恒定的。凝胶过滤表明活性CAK是一种多蛋白复合物,免疫沉淀实验确定了34kD和32kD的两种多肽可能是p40MO15的复合物伙伴。这三种蛋白质的结合在化学计量上接近,并且在整个细胞周期中保持不变。免疫细胞化学和生化去核实验均表明,p40MO15在细胞周期的所有阶段(有丝分裂除外,此时该蛋白重新分布于整个细胞)都位于细胞核中,尽管CAK的主要假定底物之一p34cdc2/细胞周期蛋白B复合物在有丝分裂前不久才出现在细胞质中。在指数生长的细胞中CAK活性没有明显变化,这令人惊讶。这表明p34cdc2中苏氨酸161(以及其他cdks中的相应残基)的磷酸化状态可能主要由cdk/细胞周期蛋白底物的可用性以及磷酸酶来调节。